Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Ondine Biomedical Inc - Vancouver-based life sciences company specialising in photodisinfection therapies - Partners with Kelowna General Hospital in Canada for a pilot program to prevent hospital-acquired infections using its Steriwave nasal photodisinfection therapy. Says Steriwave is already in use at a number of hospitals acrsoss Canada.
Chief Executive Officer Carolyn Cross says: ‘We believe that every patient deserves the best protection against HAIs. By wiping out the pathogens in the nose, which is a major reservoir for these potentially fatal pathogens, our photodisinfection treatment can reduce HAIs following major surgeries by up to 80%.’
Current stock price: 16.23 pence, up 1.4% on Monday
12-month change: down 58%
Copyright 2023 Alliance News Ltd. All Rights Reserved.